Reserve Bank of Australia says the labor market remains slightly tight and is expected to stay stable in the near term before gradually easing.

Key News 1. The People's Bank of China: Improve the framework of a modern monetary policy with Chinese characteristics and refine the mechanism for issuing base money. 2. The National Development and Reform Commission and the National Energy Administration: Accelerate the optimization and upgrading of the coal industry structure and promote the exit of outdated and ineffective production capacity. 3. The Ministry of Commerce: Preliminary findings indicate that imported pecans originating from Mexico and the United States are being dumped. Stock News 1. Unitree Automation: After the clawback mechanism was activated, the final online subscription rate was 0.01809759%. 2. Jiangbolong: Net profit for the first half of 2026 was RMB 10.577 billion, a year-on-year increase of 71,528.66%. 3. GigaDevice: A subsidiary invested US$100 million to subscribe to private equity fund shares. 4. Zhaojin Gold: Significant fluctuations in gold prices in the future will have a substantial impact on the company's operating performance. 5. Sources confirm that EVE Energy will raise prices for two types of batteries; industry insiders say this may affect subsequent electric vehicle pricing. 6. Aili Home Furnishings: Trading of its shares fluctuated abnormally; trading was suspended on August 11th for investigation. 7. Yisheng Bio-tech: July sales revenue of broiler chicks increased by 113% year-on-year. 8. Leadcore Technology (two consecutive daily limit-up): Its main business does not include indium phosphide substrates, and it has no revenue or profit related to indium phosphide substrates. 9. Xinlian Integrated Circuits: First-half net profit turned around to 278 million yuan, achieving a turnaround from a loss year-on-year. It has deployed technology platforms and product matrices in the fields of AI infrastructure and optical interconnects. 10. Gan & Lee Pharmaceuticals: Licensed Menarini to commercialize its bovangravitide for overweight or obesity in the EU-27 and other regions, with milestone payments up to €664 million.

Reserve Bank of Australia Governor Bullock: Not concerned about the vulnerability of private credit.